These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9928993)
1. Formation of titanium(IV) transferrin by reaction of human serum apotransferrin with titanium complexes. Messori L; Orioli P; Banholzer V; Pais I; Zatta P FEBS Lett; 1999 Jan; 442(2-3):157-61. PubMed ID: 9928993 [TBL] [Abstract][Full Text] [Related]
2. Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride. Guo M; Sun H; McArdle HJ; Gambling L; Sadler PJ Biochemistry; 2000 Aug; 39(33):10023-33. PubMed ID: 10955990 [TBL] [Abstract][Full Text] [Related]
3. Calorimetric, spectroscopic, and model studies provide insight into the transport of Ti(IV) by human serum transferrin. Tinoco AD; Incarvito CD; Valentine AM J Am Chem Soc; 2007 Mar; 129(11):3444-54. PubMed ID: 17315875 [TBL] [Abstract][Full Text] [Related]
5. Redox potentials of Ti(IV) and Fe(III) complexes provide insights into titanium biodistribution mechanisms. Parker Siburt CJ; Lin EM; Brandt SJ; Tinoco AD; Valentine AM; Crumbliss AL J Inorg Biochem; 2010 Sep; 104(9):1006-9. PubMed ID: 20569990 [TBL] [Abstract][Full Text] [Related]
6. A mechanism for iron uptake by transferrin. Pakdaman R; El Hage Chahine JM Eur J Biochem; 1996 Mar; 236(3):922-31. PubMed ID: 8665914 [TBL] [Abstract][Full Text] [Related]
8. Hydrolytic metal with a hydrophobic periphery: titanium(IV) complexes of naphthalene-2,3-diolate and interactions with serum albumin. Tinoco AD; Eames EV; Incarvito CD; Valentine AM Inorg Chem; 2008 Sep; 47(18):8380-90. PubMed ID: 18710217 [TBL] [Abstract][Full Text] [Related]
9. Iron binding to apotransferrin. Weaver J; Pollack S Acta Haematol; 1990; 84(2):68-71. PubMed ID: 2120888 [TBL] [Abstract][Full Text] [Related]
10. Calorimetry of the transfer of Fe(3) from nitrilotriacetate to apotransferrin in the presence and in the absence of bicarbonate. Binford JS; Foster JC J Biol Chem; 1974 Jan; 249(2):407-12. PubMed ID: 4809525 [No Abstract] [Full Text] [Related]
11. Unusual features for zirconium(IV) binding to human serum transferrin. Zhong W; Parkinson JA; Guo M; Sadler PJ J Biol Inorg Chem; 2002 Jun; 7(6):589-99. PubMed ID: 12072964 [TBL] [Abstract][Full Text] [Related]
12. Apotransferrin receptors and the delivery of iron from cultured human blood monocytes. Baynes RD; Bukofzer G; Bothwell TH; Bezwoda WR Am J Hematol; 1987 Aug; 25(4):417-25. PubMed ID: 3618589 [TBL] [Abstract][Full Text] [Related]
13. The role of citrate, lactate and transferrin in determining titanium release from surgical devices into human serum. Curtin JP; Wang M; Cheng T; Jin L; Sun H J Biol Inorg Chem; 2018 May; 23(3):471-480. PubMed ID: 29623422 [TBL] [Abstract][Full Text] [Related]
14. Titanium preferential binding sites in human serum transferrin at physiological concentrations. Nuevo-Ordoñez Y; Montes-Bayón M; Blanco González E; Sanz-Medel A Metallomics; 2011 Dec; 3(12):1297-303. PubMed ID: 22041858 [TBL] [Abstract][Full Text] [Related]
15. Periodate modification of human serum transferrin Fe(III)-binding sites. Inhibition of carbonate insertion into Fe(III)- and Cu(II)-chelator-transferrin ternary complexes. Ross DC; Egan TJ; Purves LR J Biol Chem; 1995 May; 270(21):12404-10. PubMed ID: 7759481 [TBL] [Abstract][Full Text] [Related]
16. Steric restrictions on the binding of large metal ions to serum transferrin. Harris WR; Yang B; Abdollahi S; Hamada Y J Inorg Biochem; 1999 Sep; 76(3-4):231-42. PubMed ID: 10605839 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells. Hernández R; Lamboy J; Gao LM; Matta J; Román FR; Meléndez E J Biol Inorg Chem; 2008 Jun; 13(5):685-92. PubMed ID: 18288505 [TBL] [Abstract][Full Text] [Related]
18. Interaction of manganese(II) complex with apotransferrin and the apotransferrin enhanced anticancer activities. Yao L; Chen QY; Xu XL; Li Z; Wang XM Spectrochim Acta A Mol Biomol Spectrosc; 2013 Mar; 105():207-12. PubMed ID: 23314213 [TBL] [Abstract][Full Text] [Related]
19. Proposal for the standardization of the serum unsaturated iron binding capacity assay, and results in groups of subjects with normal iron stores and with prelatent, latent, and manifest iron deficiency. Gabbe EE; Heinrich HC; Icagić F Clin Chim Acta; 1982 Feb; 119(1-2):51-63. PubMed ID: 7060275 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of formation of the complex between transferrin and bismuth, and interaction with transferrin receptor 1. Miquel G; Nekaa T; Kahn PH; Hémadi M; El Hage Chahine JM Biochemistry; 2004 Nov; 43(46):14722-31. PubMed ID: 15544343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]